Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Novus Medical Detox Center: U.S. Opioid Addiction Reaches Pandemic Levels
  • USA - English


News provided by

JoTo PR

Sep 06, 2016, 08:00 ET

Share this article

Share toX

Share this article

Share toX

Kent Runyon, Vice President of Community Relations and Compliance Officer of Novus Medical Detox Center, comments on the alarming statistics of opioids in America.
Kent Runyon, Vice President of Community Relations and Compliance Officer of Novus Medical Detox Center, comments on the alarming statistics of opioids in America.

NEW PORT RICHEY, Fla. (PRWEB) September 06, 2016 -- Data from the Centers for Disease Control and Prevention indicates that the current opioid epidemic may be the worst drug crisis in American history, with death rates now rivaling those of AIDS during the 1980s and 1990s. As an indicator of its severity, CDC notes that in 1999 there were more than twice as many motor vehicle deaths in the U.S. as there were fatal drug overdoses. By 2014, those numbers had flipped, with almost 40% more deaths from overdoses than car crashes.1

We aren’t just dealing with a crime problem, or a substance abuse problem. We’re dealing with a public health crisis.

Post this

“Just as we did with AIDS, we need to address this situation on every level,” says Kent Runyon, Vice President of Community Relations and Compliance Officer of Novus Medical Detox Center, a leading Florida-based drug treatment facility. “We aren’t just dealing with a crime problem, or a substance abuse problem. We’re dealing with a public health crisis.”

Some parts of the country have been hit harder than others, and one of the hardest-hit is Florida. Going back to 2011, authorities in Florida were describing the state as the epicenter of a prescription drug abuse epidemic, as doctors in Florida were prescribing 10 times more oxycodone pills than every other state in the country. A representative of the Broward County Sheriff’s Department, speaking at the time, said, “We have more pain clinics than McDonald’s. They’re taking their toll.”2

Since then, increased awareness of the danger of opioids among physicians, accompanied by a crackdown by law enforcement at the state, federal, and local levels, has succeeded in making oxycodone and other prescription opioids at least somewhat more difficult to obtain. Unfortunately, public awareness of the effectiveness of available addiction treatment modalities has not kept pace with law-enforcement and prescription-limiting initiatives. Even more unfortunately, Runyon notes, is that the reduced availability of prescription opioids coincided with the widespread and low-priced availability of illegal alternatives, particularly heroin and an even more dangerous and potent painkiller, fentanyl.

Here too Florida is a pacesetter. According to a report from the Florida Department of Law Enforcement, heroin deaths jumped 100% in Miami-Dade, almost 210% in Broward, and 425% in Palm Beach counties in the first half of 2015 compared to the same period in the previous year. Deaths linked to fentanyl skyrocketed 310% in Miami-Dade and 100% in Broward. Public health and toxicology experts say the nearly uniform upward trends have continued through the second half of 2015 into 2016. The wave of opioid abuse has been particularly grim in South Florida, where a crackdown on prescription painkillers such as oxycodone is believed to have led to the spike in heroin and fentanyl abuse.3

“You can see just how intractable this problem can be,” says Runyon. “It often begins with a doctor overprescribing opioids for pain—or a patient seeking greater pain relief than his or her prescription offers. Unfortunately, once the immediate painkilling effect has worn off, a side effect of opioid use is more severe and more protracted pain. At this point, the abrupt untreated withdrawal from one drug can very easily lead to the search for a substitute, which is where the heroin and fentanyl come in. What’s needed for people in pain are non-opioid treatment options. For people already in dependency or addiction, treatment—medically supervised, individualized treatment—is essential.”

Novus has helped many patients successfully manage opiate and opioid withdrawal through its medically supervised drug detox programs. The Florida drug detox facility uses proven medical protocols to create a customized treatment plan for each patient, and offers 24-hour access to nursing care and withdrawal specialists. Novus is widely recognized for its expertise in treating high-dose methadone cases, and is proficient in detoxing patients from other high-dose opioids just as safely, comfortably and effectively.

For more information on Novus Medical Detox Center and its opioid treatment programs, visit http://www.novusdetox.com.

About Novus Medical Detox Center:
Novus Medical Detox Center has earned The Joint Commission’s Gold Seal of Approval for Behavioral Health Care Accreditation as an inpatient medical detox facility. Licensed by the Florida Department of Children and Families, Novus provides safe, effective alcohol and drug treatment programs that are based on proven medical protocols and designed to minimize the discomfort of withdrawal. The facility is located on 3.25 acres in New Port Richey, Florida, in a tranquil, spa-like setting bordering protected conservation land. Intent on proving that detox doesn’t have to be painful or degrading, Novus set out to transform the industry by bringing humanity into medical detox with individually customized treatment programs and 24/7 access to nursing care and withdrawal specialists. Today, Novus is renowned as a champion of industry standardization and a staunch advocate of patients fighting to overcome substance use disorders. Frequently recognized for its contributions to the industry and local community, Novus has become a regular source to media publications such as The Wall Street Journal and USA Today, and has ranked in the Tampa Bay Business Journal’s Fast 50, the Florida Business Journal’s Top 500 and the Inc. 5000 list of America’s fastest-growing companies. For more information on Novus’ medically supervised detox programs, visit http://novusdetox.com.

1. Nolan, Dan, and Amico, Chris, “How Bad is the Opioid Epidemic?”, PBS Frontline, February 23, 2016. http://www.pbs.org/wgbh/frontline/article/how-bad-is-the-opioid-epidemic/

2. Allen, Greg, “The ‘Oxy Express’: Florida’s Drug Abuse Epidemic,” NPR Morning Edition, March 2, 2011. http://www.npr.org/2011/03/02/134143813/the-oxy-express-floridas-drug-abuse-epidemic

3. Ovalle, David, and Weaver, Jay, “Heroin, fentanyl a deadly duo as Florida overdose deaths skyrocket,” Miami Herald, April 29, 2016. http://www.miamiherald.com/news/local/article74781717.html

Karla Jo Helms, JoTo PR, +1 (888) 202-4614 Ext: 802, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.